Device Cmf & Thoracic

Sternalock 360 System

Payments companies reported to CMS as associated with Sternalock 360 System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.9Massociated payments (2023-2025)
223clinicians with associated payments
1company reporting

By year

2023 $637K
2024 $714K
2025 $504K

Payments reported as associated with Sternalock 360 System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $1.1M
Surgery $310K
Orthopaedic Surgery $289K
Optometrist $154K
Surgical $5,962
Physician Assistant $1,198

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Sternalock 360 System

These are the largest totals companies reported as associated with Sternalock 360 System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jaishankar Raman Burr Ridge, IL Surgery $308,154.65
Jeremy London Savannah, GA Thoracic Surgery (Cardiothoracic Vascular Surgery) $308,132.13
Harvey Garrett Memphis, TN Thoracic Surgery (Cardiothoracic Vascular Surgery) $289,217.34
John Burkus Columbus, GA Orthopaedic Surgery $289,196.32
John Pirris Jacksonville, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $289,196.32
Kari Riina Fishers, IN Optometrist $154,078.32
Darien Bradford Burleson, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $40,657.79
Mark Bonnell Chattanooga, TN Thoracic Surgery (Cardiothoracic Vascular Surgery) $40,657.79
John Grehan Sioux Falls, SD Thoracic Surgery (Cardiothoracic Vascular Surgery) $40,657.79
J Morales Corpus Christi, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $20,309.07

Prescribed Sternalock 360 System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.